Çocukluk çağı idrar yolu enfeksiyonlarında Escherichia coli ve antibiyotik direnci

SDÜ Tıp Fakültesi Dergisi; Vol 13, No 2 (2006) 01/2006;
Source: OAI

ABSTRACT SüleymanDemirel Üniversitesi TIP FAKÜLTESİ DERGİSİ: 2006 Haziran; 13(2) Çocukluk çağı idrar yolu enfeksiyonlarında Escherichia coli ve antibiyotik direnci Hasan Çetin, Faruk Öktem, Ahmet R. Örmeci, Birdal Yorgancıgil, Güler Yaylı Özet EGb Mannitol ve U74389F ile karşılaştırmalı olarak serebral iskemi üzerine koruyucu rolü Amaç: Çocukluk çağında idrar yolu enfeksiyonları ve antibiyotik direnci halen önemli bir sağlık sorunudur. Bu çalışmada E. coli ile gelişen idrar yolu enfeksiyonunda antibiyotik direncini ve yıllar içinde antibiyotik direncinde gelişen değişiklikleri ortaya çıkarmayı amaçladık. Yöntem: İdrar yolu enfeksiyonu olan çocukların mikrobiyolojik sonuçlarını retrospektif olarak değerlendirdik. Bulgular: İki yılda E. coli ile gelişen toplumdan kazanılmış idrar yolu enfeksiyonu olan 132 çocuk vardı. Ampisiline %79, ampisilin-sulbaktama %63.2, amoksisilin klavunata %53, ko-trimoksazole %82.2, gentamisine %6.6, netilmisine %10, amikasine %11.5, sefuroksime %21.9 ve seftriaksona %6.8 oranında direnç saptandı. Ko-trimoksazole karşı dirençte 3 yıl içinde anlamlı artış görüldü (p

2,099 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: In order to determine the etiological agents and the rate of resistance to various antibiotics, 209 consecutive gram-negative bacteria isolated from children admitted to Hacettepe University Children's Hospital with urinary tract infections were investigated over a three-month period. Of these, 46 (22%) were nosocomial isolates. The most frequently isolated organism was E.coli (n: 141) followed by Klebsiella spp. (39), Proteus spp. (19), Pseudomonas spp. (8) and Enterobacter spp. (2). In vitro susceptibilities were evaluated by microbroth dilution method, following NCCLS guidelines. Overall, 75 percent of the isolates were resistant to ampicillin, 52 percent were resistant to TMP/SMX and 25 percent to cefuroxime. Amikacin was the most active aminoglycoside; 93 percent of the isolates were susceptible to this agent, while resistance to gentamicin was 21 percent. Resistance to ceftazidime and ceftriaxone was 12 percent and 19 percent, respectively. Overall, resistance to imipenem was one percent and to ciprofloxacin three percent. These in vitro results should be taken into account before initiating empirical therapy; broad spectrum antibiotics should not be used if the isolate is susceptible to the older drugs in order to prevent the increase in resistance.
    The Turkish journal of pediatrics 01/1999; 41(1):37-42. · 0.43 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The most common oral antibiotics used in the treatment of urinary tract infection (UTI) are sulphonamides and cephalosporins, but emerging resistance is not unusual. To assess the change in susceptibility of urinary pathogens to oral antibiotics during the past decade in children with community acquired UTI. The study sample included two groups of children with a first community acquired UTI: 142 children enrolled in 1991 and 124 enrolled in 1999. UTI was diagnosed by properly collected urine specimen (suprapubic aspiration, transurethral catheterisation, or midstream specimen in circumcised males) in symptomatic patients. Antimicrobial susceptibility of the isolates was compared between the two groups. The pathogens recovered in the two groups were similar: in 1991--E coli 86%, Klebsiella 6%, others 8%; in 1999--E coli 82%, Klebsiella 13%, and others 5%. A slight but generalised decrease in bacterial susceptibility to common antibiotics in the two groups was shown: ampicillin 35% versus 30%; cephalexin 82% versus 63% (p < 0.001); nitrofurantoin 93% versus 92%. The only exception was co-trimoxazole, 60% versus 69%. Overall resistance to antibiotics in 1999 was as follows: ampicillin 70%, cephalexin 37%, co-trimoxazole 31%, amoxicillin-clavulanate 24%, nitrofurantoin 8%, cefuroxime-axetil 5%, nalidixic acid 3%. This study shows a slight but generalised decrease in bacterial susceptibility to common oral antibiotics in the past decade in our population. Empirical initial treatment with co-trimoxazole or cephalexin is inadequate in approximately one third of UTI cases. A larger number of pathogens may be empirically treated with amoxicillin-clavulanate (24% resistance); 95% of organisms are susceptible to cefuroxime-axetil.
    Archives of Disease in Childhood 04/2003; 88(3):215-8. DOI:10.1136/adc.88.3.215 · 2.90 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In order to monitor changes in the frequency and antimicrobial resistance of urinary pathogens over several years, urinary cultures received from outpatient clinics and from a hospital during a period of one month each in 1991 and 1995 were analyzed at a clinical microbiology laboratory. In 1991 and 1995, 1366 and 1534 significant monomicrobic cultures respectively were reviewed. The frequency of Escherichia coli dropped significantly in the outpatient clinics from 70.5% to 61.2% (p < 0.0001). The frequency of Proteus mirabilis, Morganella morganii, Pseudomonas aeruginosa and other gram-negative bacteria also decreased, but the frequency of Klebsiella spp. and Enterobacter spp. increased from 2.6% to 5.8% (p < 0.0001). In the hospital, the frequency of Enterobacter spp. (p < 0.04), Escherichia coli and Morganella morganii declined from 1991 to 1995, whereas the frequency of Pseudomonas aeruginosa (p = 0.001), Acinetobacter spp. (p < 0.05), Klebsiella spp., Proteus mirabilis and other gram-negative rods increased considerably. The frequency of gram-positive aerobic bacteria rose markedly in outpatient specimens from 6.1% to 13.5% (p < 0.0001), while a decline from 14.4% to 9.3% was noted in hospital specimens (p < 0.02). A significant rise in the resistance of Escherichia coli to gentamicin and ciprofloxacin (p < 0.0001) was detected in outpatient isolates. In the hospital, gram-negative urinary pathogens demonstrated increased resistance to ampicillin (p = 0.042), cefuroxime (p = 0.005), gentamicin (p = 0.002) and ciprofloxacin (p < 0.0001) during the study period. The changing etiology of urinary tract infections and the increasing resistance of organisms indicate that periodic monitoring and possibly also modification of empirical therapy are required.
    European Journal of Clinical Microbiology 12/1997; 16(11):834-8. DOI:10.1007/BF01700414 · 2.67 Impact Factor
Show more